Company Analysis Alterola Biotech Inc
1. Summary
Advantages
- Price (0.004 $) is less than fair price (0.0101 $)
- Current debt level 0% is below 100% and has decreased over 5 years from 7547.43%.
Disadvantages
- Dividends (0%) are below the sector average (0%).
- The stock's return over the last year (-54.02%) is lower than the sector average (8.52%).
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=0%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Alterola Biotech Inc | Index | ||
|---|---|---|---|
| 7 days | -59.2% | -0.2% | 0.4% |
| 90 days | -80% | 5.4% | 4% |
| 1 year | -54% | 8.5% | 25.2% |
ABTI vs Sector: Alterola Biotech Inc has significantly underperformed the "" sector by -62.54% over the past year.
ABTI vs Market: Alterola Biotech Inc has significantly underperformed the market by -79.19% over the past year.
Slightly volatile price: ABTI is more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: ABTI with weekly volatility of -1.04% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.004 $) is lower than the fair price (0.0101 $).
Price significantly below the fair price: The current price (0.004 $) is 152.5% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is higher than that of the sector as a whole (0).
P/E vs Market: The company's P/E (0) is higher than that of the market as a whole (0).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0) is higher than that of the sector as a whole (0).
P/BV vs Market: The company's P/BV (0) is higher than that of the market as a whole (0).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is higher than that of the sector as a whole (0).
P/S vs Market: The company's P/S indicator (0) is higher than that of the market as a whole (0).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is higher than that of the sector as a whole (0).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is higher than that of the market as a whole (0).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Earnings Slowdown: The last year's return (-100%) is below the 5-year average return (-20%).
Profitability vs Sector: The return for the last year (-100%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (0%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (0%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (0%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (0%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
